ULURU INC. ANNOUNCES APPROVAL TO MARKET ALTRAZEAL® IN AUSTRALIA

02/23/2012

Addison, Texas, February 23, 2012; ULURU Inc. (NYSE AMEX: ULU), announced today that an Australian Register of Therapeutic Goods Certificate has been issued by the Therapeutic Goods Administration approving the marketing of Altrazeal® in Australia. Read More